Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prostate cancer in Denmark. Incidence, morbidity and mortality

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Carcinoma of the prostate. Classification

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Carcinoma of the prostate. Early diagnosis--screening

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Carcinoma of the prostate. Prognostic factors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Prostate cancer incidence and mortality rates in Denmark are reviewed for a 50-year period from 1943 to 1992. The prostate cancer incidence rate nearly tripled and prostate cancer mortality rate increased during this period. Until recently in Denmark the routine management of prostate cancer has been by deferred hormonal therapy. Morbidity and mortality associated with prostate cancer are analysed in a group of 1459 patients aged 55-74 years, who were diagnosed as having clinically localized prostate cancer in the 5-year period 1983 to 1987. In this group of patients prostate cancer is demonstrated to cause significant morbidity. Furthermore, the patients suffered significant excess mortality and loss of life expectancy.
OriginalsprogEngelsk
BogserieScandinavian Journal of Urology and Nephrology. Supplement
Vol/bind203
Sider (fra-til)29-33
Antal sider5
ISSN0300-8886
StatusUdgivet - 1999

ID: 36730531